Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Huret

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Cell Stem Cell|December 20, 2016
XACT Noncoding RNA Competes with XIST in the Control of X Chromosome Activity during Human Early DevelopmentCéline Vallot, Catherine Patrat, Amanda J Collier, et al.
Cancer Research|November 7, 2025
Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and PatientsLéa Baudre, Grégoire Jouault, Pacôme Prompsy, et al.
Cancer Research|November 6, 2025
Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and PatientsLéa Baudre, Gregoire Jouault, Pacôme Prompsy, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Cell Stem Cell|December 20, 2016
XACT Noncoding RNA Competes with XIST in the Control of X Chromosome Activity during Human Early DevelopmentCéline Vallot, Catherine Patrat, Amanda J Collier, et al.
Cancer Research|November 7, 2025
Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and PatientsLéa Baudre, Grégoire Jouault, Pacôme Prompsy, et al.
Cancer Research|November 6, 2025
Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and PatientsLéa Baudre, Gregoire Jouault, Pacôme Prompsy, et al.
Pageof 2